Pratik Panels Ltd

Key quarterly highlights

• Quarter ended 30 Jun 2026: Revenue from operations 172.05; Other income 18.42.
• Total revenue 190.47; PAT 9.49; PBT 12.68; tax 3.19.
• EPS (basic; continuing): 0.01; (diluted): 0.01.
• Cost items: purchase of stock-in-trade 227.68; inventories -74.05; employee benefits 6.16.
• Finance cost 0.33; other expenses -17.68.
• Notes: one textile segment; limited review by statutory auditors; board record date 14 Aug 2026.

Rights issue cancellation

• Rights issue announced on 7 May 2026 has been revoked by the Rights Issue Committee.
• Board recommendation followed during the meeting held on 15 July 2026.

Meeting rescheduled and agenda

• The Rights Issue Committee meeting has been rescheduled to July 15, 2026.
• Original date: June 30, 2026.
• Earlier rescheduled date: July 6, 2026.
• Agenda: fix record date, issue price, entitlement ratio for proposed Rights Issue.
• Other matters related to the Rights Issue may be considered with Chairman's permission.
• Reason: pending in-principle approvals from stock exchanges/regulatory authorities.
• Subject to approvals by stock exchanges or regulators.

Summary of dematerialisation compliance

• Processing of dematerialisation requests for the reporting quarter completed; dematerialised securities listed on stock exchanges.
• Certificates for dematerialisation were mutilated and cancelled after verification, with the depository's name updated as registered owner.

Meeting rescheduled

• Original date: 30 June 2026.
• New date: 6 July 2026.
• Agenda: fix record date, issue price, entitlement ratio, and related rights issue matters.
• Reason: pending in-principle approvals from stock exchanges/regulators.
• Subject to approvals by stock exchanges/regulatory authorities.
• Trading window status not mentioned.

Meeting Details

• Rights Issue Committee meeting on June 30, 2026 to fix record date, price and entitlement ratio.

Key Agenda Items

• Fix record date, price and entitlement ratio for the proposed Rights Issue (Rs 40.25 crore ceiling).
• Subject to approvals by stock exchanges and other regulatory authorities.
• Operationalize Board-approved rights issue terms by the Rights Issue Committee.

Other Notes

• Rights Issue ceiling of Rs 40.25 crore approved by Board on May 7, 2026; subject to regulatory approvals.

🗓️ Meeting Details

• Board meeting scheduled for 14 February 2026 at the company's registered office.

📊 Financial Performance

• Approval of unaudited standalone financial results for the quarter ended 31 December 2025.
• Consideration of Limited Review Report for the quarter ended 31 December 2025.

Resignation of Directors/KMP

• Mr. Pratik Satish Patil resigned as Whole-Time Director & CFO effective 20 January 2026.
• Mrs. Ashma Dilip Phadnis resigned as Non-Executive Independent Director effective 20 January 2026.

Appointment of Directors/KMP

• Mrs. Bhumika Nair appointed as Additional Non-Executive Independent Director effective 21 January 2026 for a 5-year term, subject to shareholder approval.
• Mrs. Bhumika Nair has 10+ years’ experience in healthcare, specializing in billing, claims, underwriting, and insurance technical functions.
• Mr. Swapnil Shimpi appointed as Whole-Time Director & CFO effective 21 January 2026 for a 3-year term, subject to shareholder approval.
• Mr. Swapnil Shimpi is a Management Graduate with 32 years’ experience in Textile, Retail, FMCG, finance, and compliance.

Compliance and Disclosures

• Neither Mrs. Bhumika Nair nor Mr. Swapnil Shimpi is debarred or disqualified by SEBI or other authorities.
• Neither is disqualified under Section 164 of the Companies Act, 2013.
• No relationships with other directors or KMP disclosed for new appointees.